Nuzenio

Marketbeat Arcutis Biotherapeutics

Marketbeat Arcutis Biotherapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 05:38:56 GMTArcutis Biotherapeutics (NASDAQ:ARQT) Raised to "Strong-Buy" at Wall Street Zen - MarketBeat
Fri, 07 Aug 2026 10:56:49 GMTAnalysts Set Expectations for ARQT Q1 Earnings - MarketBeat
Thu, 06 Aug 2026 18:05:40 GMTArcutis Biotherapeutics (NASDAQ:ARQT) Given New $40.00 Price Target at Needham & Company LLC - MarketBeat
Thu, 06 Aug 2026 03:40:57 GMTArcutis Biotherapeutics (NASDAQ:ARQT) Insider Patrick Burnett Sells 955 Shares of Stock - MarketBeat
Thu, 06 Aug 2026 03:24:32 GMTInsider Selling: Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells $114,275.00 in Stock - MarketBeat
Thu, 06 Aug 2026 03:19:08 GMTArcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells $32,127.60 in Stock - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Marketbeat Arcutis Biotherapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.